- cafead   Apr 26, 2024 at 11:22: AM
via AbbVie (ABBV.N) raised its annual profit forecast on Friday after strong sales of its immunology drug Skyrizi and cancer drug Imbruvica helped the company beat Wall Street estimates for the first quarter.
article source
article source